Fig. 4. Reduction in P53 levels does not ameliorate the phenotype of the Smn2B/− mouse model.
a Representative images of mice with the various genotypes within experimental litters at P15. Scale bar = 1 cm. b Bar chart (mean ± SEM) shows that there is a significant decrease in P53 at the transcript level in the spinal cord of Smn2B/+; P53−/− mice compared to Smn2B/+; P53+/+ mice and in Smn2B/−; P53−/− mice compared to Smn2B/−; P53+/+ mice (by Mann–Whitney-U test, *p < 0.05, **p < 0.001; n = 3 for Smn2B/−; P53+/+, n = 4 for all other genotypes). c The graph (mean ± SEM) shows body weight in Smn2B/+; P53+/+ and Smn2B/+; P53−/− on the left and Smn2B/−; P53+/+ and Smn2B/−; P53−/− on the right. There is a significant reduction of weight in mice that are P53−/− in both Smn2B/+ and Smn2B/− groups, compared to P53+/+ mice. Two-way ANOVA with multiple comparison *P < 0.05; *P < 0.001 (d, e) Graphs (mean ± SEM, with individual data points showing mean of three trials for individual animals) shows performance in the time to right test (d) and the time to turn around test (e) for Smn2B/+; P53+/+, Smn2B/−; P53+/+, Smn2B/+; P53−/− and Smn2B/−; P53−/− at P8 and P10 (d) and between P12 and P15 (e). In both tests, at all-time points, there is no significant difference in motor performance between Smn2B/−; P53−/− and Smn2B/−; P53+/+ mice. At P13, 14 and 15, Smn2B/−; P53−/− displayed a significantly longer time to turn around than Smn2B/+; P53−/− controls. (Kruskal Wallis with Dunn’s multiple comparison test; ns > 0.05, *p < 0.05, **p < 0.01, n = 5 for Smn2B/+; P53+/+ and Smn2B/−; P53+/+; n = 4 for Smn2B/+; P53−/−; n = 3 for Smn2B/−; P53−/− for all time points except P15 where n = 4 for Smn2B/+; P53+/+ and Smn2B/+; P53−/−; n = 6 for Smn2B/−; P53+/+ and n = 5 for Smn2B/−; P53−/−